Literature DB >> 21734132

Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh.

Genève M Allison1, Kathleen A Rogers, Anoli Borad, Sabeena Ahmed, Mohammad Mahbubul Karim, Anne V Kane, Patricia L Hibberd, Elena N Naumova, Stephen B Calderwood, Edward T Ryan, Wasif A Khan, Honorine D Ward.   

Abstract

Although Cryptospridium hominis is the dominant Cryptosporidium species infecting humans, immune responses to cognate antigens in C. hominis-infected persons have not been reported. We investigated antibody responses to the immunodominant gp15 antigen from C. hominis and C. parvum, in C. hominis-infected Bangladeshi children less than five years of age with diarrhea (cases) and uninfected children with diarrhea (controls). We also investigated polymorphisms in the C. hominis gp15 sequence from cases. Serum IgG responses to gp15 from both species were significantly greater in cases than controls. In spite of polymorphisms in the gp15 sequence, there was a significant correlation between antibody levels to gp15 from both species, indicating cross-reactivity to conserved epitopes. Cases with acute diarrhea had a significantly greater serum IgA response to gp15 compared with those with persistent diarrhea, suggesting that this response may be associated with protection from prolonged disease. These findings support further investigation of gp15 as a vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734132      PMCID: PMC3122351          DOI: 10.4269/ajtmh.2011.11-0043

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses.

Authors:  Wasif A Khan; Kathleen A Rogers; Mohammad Mahbubul Karim; Sabeena Ahmed; Patricia L Hibberd; Stephen B Calderwood; Edward T Ryan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2004-10       Impact factor: 2.345

Review 2.  Prevention and treatment of cryptosporidiosis in immunocompromised patients.

Authors:  I Abubakar; S H Aliyu; C Arumugam; P R Hunter; N K Usman
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  A two-year follow-up survey of antibody to Cryptosporidium in Jackson County, Oregon following an outbreak of waterborne disease.

Authors:  F J Frost; R L Calderon; T B Muller; M Curry; J S Rodman; D M Moss; A A de la Cruz
Journal:  Epidemiol Infect       Date:  1998-08       Impact factor: 2.451

4.  Major antigens of Cryptosporidium parvum recognised by serum antibodies from different infected animal species and man.

Authors:  J M Répérant; M Naciri; S Iochmann; M Tilley; D T Bout
Journal:  Vet Parasitol       Date:  1994-10       Impact factor: 2.738

5.  Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth.

Authors:  W Checkley; L D Epstein; R H Gilman; R E Black; L Cabrera; C R Sterling
Journal:  Am J Epidemiol       Date:  1998-09-01       Impact factor: 4.897

6.  Enzyme-linked immunoelectrotransfer blot analysis of a cryptosporidiosis outbreak on a United States Coast Guard cutter.

Authors:  D M Moss; S N Bennett; M J Arrowood; S P Wahlquist; P J Lammie
Journal:  Am J Trop Med Hyg       Date:  1998-01       Impact factor: 2.345

7.  Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa.

Authors:  K Mølbak; M Andersen; P Aaby; N Højlyng; M Jakobsen; M Sodemann; A P da Silva
Journal:  Am J Clin Nutr       Date:  1997-01       Impact factor: 7.045

8.  Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh.

Authors:  M J Albert; A S Faruque; S M Faruque; R B Sack; D Mahalanabis
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Seropositive human subjects produce interferon gamma after stimulation with recombinant Cryptosporidium hominis gp15.

Authors:  Geoffrey A Preidis; Heuy-Ching Wang; Dorothy E Lewis; Alejandro Castellanos-Gonzalez; Kathleen A Rogers; Edward A Graviss; Honorine D Ward; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

10.  Cryptosporidium infection in children in urban Bangladesh.

Authors:  M K Bhattacharya; T Teka; A S Faruque; G J Fuchs
Journal:  J Trop Pediatr       Date:  1997-10       Impact factor: 1.165

View more
  18 in total

1.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

3.  Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India.

Authors:  Sitara Swarna Rao Ajjampur; Rajiv Sarkar; Geneve Allison; Kalyan Banda; Anne Kane; Jayaprakash Muliyil; Elena Naumova; Honorine Ward; Gagandeep Kang
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

4.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

Review 5.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

6.  Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.

Authors:  John R Haserick; Deborah R Leon; John Samuelson; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

7.  Serum IgG responses and seroconversion patterns to Cryptosporidium gp15 among children in a birth cohort in south India.

Authors:  Rajiv Sarkar; Sitara Swarna Rao Ajjampur; Jayaprakash Muliyil; Honorine Ward; Elena N Naumova; Gagandeep Kang
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

8.  Serum antibody responses to polymorphic Cryptosporidium mucin antigen in Bangladeshi children with cryptosporidiosis.

Authors:  Olivia Lai; Christopher Morris; Sabeena Ahmed; Mohammed Mahbubul Karim; Wasif Khan; Honorine Ward; Roberta O'Connor
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

9.  Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study.

Authors:  Poonum S Korpe; Yue Liu; Abdullah Siddique; Mamun Kabir; Katherine Ralston; Jennie Z Ma; Rashidul Haque; William A Petri
Journal:  Clin Infect Dis       Date:  2012-12-12       Impact factor: 9.079

10.  Application of a salivary immunoassay in a prospective community study of waterborne infections.

Authors:  Andrey I Egorov; Shannon M Griffin; Honorine D Ward; Kevin Reilly; G Shay Fout; Timothy J Wade
Journal:  Water Res       Date:  2018-05-23       Impact factor: 11.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.